Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) EBIT Margin Growth (5y) (2014 - 2026)

Analysis

Resmed (RMD) EBIT Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 308.00
Mar 31, 2026 585.00
Dec 31, 2025 684.00
Sep 30, 2025 459.00
Jun 30, 2025 474.00
Mar 31, 2025 473.00
Dec 31, 2024 567.00
Sep 30, 2024 651.00
Jun 30, 2024 1,399.00
Mar 31, 2024 759.00
Dec 31, 2023 -47.00
Sep 30, 2023 172.00
Jun 30, 2023 98.00
Mar 31, 2023 387.00
Dec 31, 2022 282.00
Sep 30, 2022 752.00
Jun 30, 2022 504.00
Mar 31, 2022 621.00
Dec 31, 2021 952.00
Sep 30, 2021 875.00